Daratumumab Intravenous and Insulin Glargine (U-100) Cartridge Systems and Pens
Determining the interaction of Daratumumab Intravenous and Insulin Glargine (U-100) Cartridge Systems and Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daratumumab
Brand name: Darzalex
Synonyms: Daratumumab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daratumumab Intravenous-Insulin Glargine (U-100) Vials
- Daratumumab Intravenous-Insulin Glargine (U-300) Pens
- Daratumumab Intravenous-Insulin glargine and lixisenatide
- Daratumumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Daratumumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Daratumumab Intravenous-Insulin glulisine
- Insulin Glargine (U-100) Cartridge Systems and Pens-Darbepoetin alfa
- Insulin Glargine (U-100) Cartridge Systems and Pens-Darbepoetin alfa Injection
- Insulin Glargine (U-100) Cartridge Systems and Pens-Darbepoetin Alfa Prefilled Syringes
- Insulin Glargine (U-100) Cartridge Systems and Pens-Darbepoetin Alfa Vials
- Insulin Glargine (U-100) Cartridge Systems and Pens-Darcalma
- Insulin Glargine (U-100) Cartridge Systems and Pens-Darifenacin